Search Results

Filter
  • 1-10 of  42,069 results for ""ABATACEPT""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicentre study of 397 patients.

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/physiopathology ; Abatacept*/Abatacept*/Abatacept*/administration & dosage

  • Source: Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2024 Oct; Vol. 68, pp. 152517. Date of Electronic Publication: 2024 Jul 18.Publisher: W.B. Saunders Country of Publication: United States NLM ID: 1306053 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Clinical effectiveness of baricitinib and abatacept in patients with rheumatoid arthritis.

  • Authors : Asai S; Department of Orthopedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.; Takahashi N

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/diagnosis ; Azetidines*/Azetidines*/Azetidines*/therapeutic use

  • Source: International journal of rheumatic diseases [Int J Rheum Dis] 2024 Nov; Vol. 27 (11), pp. e15414.Publisher: Wiley on behalf of the Asia Pacific League of Associations for Rheumatology Country of Publication: England NLM ID: 101474930 Publication Model:

Record details

×
Academic Journal

Efficacy and safety of abatacept in preclinical rheumatoid arthritis: A systematic review and meta-analysis of randomized controlled trials.

  • Authors : Asif M; Department of Medicine, Services Institute of Medical Sciences, Lahore, Pakistan. Electronic address: .; Asif A

Subjects: Abatacept*/Abatacept*/Abatacept*/therapeutic use ; Abatacept*/Abatacept*/Abatacept*/adverse effects ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy

  • Source: Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2024 Dec; Vol. 69, pp. 152562. Date of Electronic Publication: 2024 Oct 04.Publisher: W.B. Saunders Country of Publication: United States NLM ID: 1306053 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Clinical efficacy study of abatacept in the treatment of rheumatoid arthritis patients in China.

  • Authors : Jiang H; Department of Rheumatology and Immunology, Center for General Practice Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, China.; The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/diagnosis ; Abatacept*/Abatacept*/Abatacept*/therapeutic use

  • Source: International journal of rheumatic diseases [Int J Rheum Dis] 2024 Oct; Vol. 27 (10), pp. e15300.Publisher: Wiley on behalf of the Asia Pacific League of Associations for Rheumatology Country of Publication: England NLM ID: 101474930 Publication Model:

Record details

×
Academic Journal

Real-world clinical outcomes and rationale for initiating abatacept as a first-line biologic for patients with anticitrullinated protein antibody- and rheumatoid factor-positive rheumatoid arthritis.

Subjects: Abatacept*/Abatacept*/Abatacept*/therapeutic use ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use

  • Source: Journal of comparative effectiveness research [J Comp Eff Res] 2024 Dec; Vol. 13 (12), pp. e230144. Date of Electronic Publication: 2024 Nov 18.Publisher: Becaris Publishing Country of Publication: England NLM ID: 101577308 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Abatacept and tofacitinib in refractory sarcoidosis: drug survival, safety, and treatment response.

  • Authors : Leffers HCB; Copenhagen Lupus and Vasculitis Clinic, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark. .; Baslund B

Subjects: Piperidines*/Piperidines*/Piperidines*/therapeutic use ; Piperidines*/Piperidines*/Piperidines*/adverse effects ; Abatacept*/Abatacept*/Abatacept*/therapeutic use

  • Source: Clinical and experimental rheumatology [Clin Exp Rheumatol] 2024 Nov; Vol. 42 (11), pp. 2167-2174. Date of Electronic Publication: 2024 Oct 03.Publisher: Clinical And Experimental Rheumatology S.A.S Country of Publication: Italy NLM ID: 8308521 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation.

  • Authors : Kean LS; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.

Subjects: Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/prevention & control ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/etiology ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/mortality

  • Source: Blood [Blood] 2024 Oct 24; Vol. 144 (17), pp. 1834-1845.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020

Record details

×
Academic Journal

Abatacept use for 24 weeks has a limited effect on salivary gland inflammation in Sjögren's disease patients.

  • Authors : Nakshbandi U; Department of Rheumatology and Clinical Immunology, University of Groningen and University Medical Center Groningen, The Netherlands. .; Liefers SC

Subjects: Abatacept*/Abatacept*/Abatacept*/therapeutic use ; Sjogren's Syndrome*/Sjogren's Syndrome*/Sjogren's Syndrome*/drug therapy ; Sjogren's Syndrome*/Sjogren's Syndrome*/Sjogren's Syndrome*/immunology

  • Source: Clinical and experimental rheumatology [Clin Exp Rheumatol] 2024 Dec; Vol. 42 (12), pp. 2362-2368. Date of Electronic Publication: 2024 Dec 19.Publisher: Clinical And Experimental Rheumatology S.A.S Country of Publication: Italy NLM ID: 8308521 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Abatacept retention and clinical effectiveness in patients with rheumatoid arthritis in a real-world setting in Taiwan.

  • Authors : Chen KH; Cathay General Hospital (CGH), Taipei, Taiwan.; Li KJ

Subjects: Abatacept*/Abatacept*/Abatacept*/therapeutic use ; Abatacept*/Abatacept*/Abatacept*/adverse effects ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy

  • Source: International journal of rheumatic diseases [Int J Rheum Dis] 2024 Jul; Vol. 27 (7), pp. e15199.Publisher: Wiley on behalf of the Asia Pacific League of Associations for Rheumatology Country of Publication: England NLM ID: 101474930 Publication Model:

Record details

×
Academic Journal

Abatacept Induces Long-Term Reconstitution of the B-Cell Niche in a Patient With CTLA-4 Haploinsufficiency: A Case Report.

  • Authors : Pfeuffer S; Department of Neurology, Justus-Liebig-University Giessen, Germany.; Nelke C

Subjects: Abatacept*/Abatacept*/Abatacept*/pharmacology ; Haploinsufficiency* ; CTLA-4 Antigen*

  • Source: Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2025 Mar; Vol. 12 (2), pp. e200351. Date of Electronic Publication: 2024 Dec 17.Publisher: Wolters Kluwer Health/Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101636388 Publication Model: Print-Electronic

Record details

×
  • 1-10 of  42,069 results for ""ABATACEPT""